TOP STORIES

• BUSINESS Pharma Industry Mixed on Off-Year Drug Price Revision Plan for FY2023
  December 19, 2022

• REGULATORY Chuikyo OKs FY2023 Price Revision Outline Specifying “0.625 Times” Product Coverage Threshold
  December 19, 2022

• REGULATORY Ministers Agree on “4.375%” Product Coverage Line for 2023 “Off-Year” Drug Price Revision
  December 16, 2022

• REGULATORY Off-Year Re-Pricing Expected to Cover 70% of Listed Products; Special Steps for Unprofitable Drugs, Patented Meds
  December 16, 2022

• BUSINESS Takeda’s HAE Drug Takhzyro Enjoying Positive Uptake in Japan: Exec
  December 15, 2022

• BUSINESS Total Sales of 25 Japan Drug Makers Up 12.9% in 1st Half, Global Players Fare Well While SMEs Falter
  December 15, 2022

• REGULATORY Japan to Refit R&D Tax Credit System to Boost Incentive; Lower Minimum Deduction Rate, Variable Cap
  December 14, 2022

• REGULATORY Japan Govt to Purchase Another 1 Million Courses of Xocova
  December 14, 2022

• COMMENTARY LDP Expects to Finalize Tax Reform Plan This Week; Will It Expand R&D Credit System?
  December 13, 2022

• REGULATORY 70% of Listed Meds Likely to Face Off-Year Re-Pricing If Prior Threshold Applied: MHLW
  December 12, 2022

• BUSINESS CSL to Bring 1st Hemophilia B Gene Therapy to Japan Too; Eyes Riveted on Price Tag
  December 9, 2022

• BUSINESS Merck CEO Wants to See Japan’s Shift to Pro-Innovation Structure in 2024 Reform
  December 9, 2022

• REGULATORY First Generics for 5 APIs Join NHI Price List, Main Targets Are Nexium/Lexapro
  December 9, 2022

• REGULATORY Industry Prods Special Inflation Measure in Off Year, Payers Don’t See Much Need: Chuikyo Hearing
  December 8, 2022

• ORGANIZATION FPMAJ Poll Finds Worsening Supply Woes with 28% of Drugs Restricted or Suspended
  December 7, 2022

• ACADEMIA Lewy Body Dementia Specialist Sees Aricept Approval Modification as Positive Move
  December 6, 2022

• REGULATORY NHI-Market Price Gap Narrowed, but Chuikyo Payer Reps Say Normal Revision Possible
  December 5, 2022

• REGULATORY Average NHI-Market Price Gap for 2023 Off-Year Revision at 7.0%: MHLW
  December 2, 2022

• BUSINESS AstraZeneca Japan Set to Buttress Respiratory Business with Tezspire Debut
  December 2, 2022

• BUSINESS Ultragenyx to Ramp Up Ultra-Orphan Drug Development, Bolster Hiring in Japan
  December 1, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 61
• 62
• 63
• 64
• 65
• 66
• 67
• 68
• 69
• …
• Next ›
• 最終 »